Identification of Key Genes of Prognostic Value in Clear Cell Renal Cell Carcinoma Microenvironment and a Risk Score Prognostic Model

Figure 4

Prognostic value of the risk score prognostic model based on ten immune-related genes in the entire TCGA cohort of patients with clear cell renal cell carcinoma. (a) Kaplan-Meier risk survival curve of high- and low-risk patients grouped according to median risk score; (b) Receiver operating characteristic curve analysis of 3-year and 5-year overall survival of the ten-gene signature; (c) Distribution of survival status, risk score, and gene expression level in patients with clear cell renal cell carcinoma. Patient subgroups with high- and low-risk scores were classified by the optimal cutoff value. The dotted line indicates the cutoff point of the median risk score used to categorize patients into low- and high-risk groups.

(a)

(b)

(c)